Shadia I. Jalal
Indiana University Health(US)Indiana Cancer Consortium(US)Richard L. Roudebush VA Medical Center(US)University School(US)Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndiana University School of MedicineIndiana University – Purdue University Indianapolis(US)Indiana University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Esophageal Cancer Research and Treatment, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer(2018)1,796 cited
- → Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study(2016)1,385 cited
- → Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology(2023)466 cited
- → Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies(2019)430 cited
- → DNA repair targeted therapy: The past or future of cancer treatment?(2016)379 cited
- → Immunotherapy in Lung Cancer: Current Landscape and Future Directions(2022)